本文選題：缺血性腦血管病　切入點(diǎn)：甲狀腺抗體　出處：《中國(guó)腦血管病雜志》2017年08期 　論文類型：期刊論文

【摘要】：正卒中已成為我國(guó)居民首要的致死原因,缺血性卒中所占比例高達(dá)70%~80%,發(fā)病率以年8.7%的速度增長(zhǎng)~([1])。隨著神經(jīng)內(nèi)分泌和神經(jīng)免疫學(xué)的發(fā)展,缺血性卒中可引起機(jī)體內(nèi)分泌代謝的改變,尤其甲狀腺抗體滴度異常較為常見,已成為目前神經(jīng)內(nèi)分泌學(xué)研究領(lǐng)域的熱點(diǎn)之一。本研究就甲狀腺相關(guān)
[Abstract]:Positive stroke has become the leading cause of death among Chinese residents. The proportion of ischemic stroke is as high as 70% and 80%. The incidence of stroke has increased at the rate of 8.7% years ([1].) with the development of neuroendocrine and neuroimmunology, Ischemic stroke can cause changes in endocrine metabolism, especially abnormal thyroid antibody titer, which has become one of the hotspots in the field of neuroendocrinology.
【作者單位】： 南京大學(xué)醫(yī)學(xué)院附屬金陵醫(yī)院南京軍區(qū)南京總醫(yī)院神經(jīng)內(nèi)科;
【基金】：國(guó)家自然科學(xué)基金青年項(xiàng)目(81501193) 南京軍區(qū)南京總醫(yī)院課題(2015038)
【分類號(hào)】：R743
，

本文編號(hào)：1643697